Bluebird bio is a company dedicated to the development of potentially transformative gene therapies for severe genetic diseases and T-cell-based immune therapies. It was founded in 1992 and is headquartered in Cambridge, Massachusetts, US. Bluebird bio has also offices in the USA and Europe and is pleased now to join the vibrant biotech community in Zug.

The company's goal is to develop and market the most advanced products based on the transformative potential of gene therapy to give patients confidence despite limited or lack of long-term, safe and effective treatment options. See what Nancy Hunter, Head of Commercial, thinks about the advantages in the Greater Zurich Area.

More about Greater Zurich as a life science hotspot

More success stories